A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice

Shuyan Liang,* Jun Hu,* Yuanyuan Xie, Qing Zhou, Yanhong Zhu, Xiangliang Yang National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, People’s Republic of China *These authors contributed equally...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liang SY, Hu J, Xie YY, Zhou Q, Zhu YH, Yang XL
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
CpG
Acceso en línea:https://doaj.org/article/14d3340247bf4804b5891b78c0fa4f48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:14d3340247bf4804b5891b78c0fa4f48
record_format dspace
spelling oai:doaj.org-article:14d3340247bf4804b5891b78c0fa4f482021-12-02T01:34:06ZA polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice1178-2013https://doaj.org/article/14d3340247bf4804b5891b78c0fa4f482016-12-01T00:00:00Zhttps://www.dovepress.com/a-polyethylenimine-modified-carboxyl-polystyreneacrylamide-co-polymer--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Shuyan Liang,* Jun Hu,* Yuanyuan Xie, Qing Zhou, Yanhong Zhu, Xiangliang Yang National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, People’s Republic of China *These authors contributed equally to this work Abstract: Cancer immunotherapy based on nanodelivery systems has shown potential for treatment of various malignancies, owing to the benefits of tumor targeting of nanoparticles. However, induction of a potent T-cell immune response against tumors still remains a challenge. In this study, polyethylenimine-modified carboxyl-styrene/acrylamide (PS) copolymer nanospheres were developed as a delivery system of unmethylated cytosine-phosphate-guanine (CpG) oligodeoxynucleotides and transforming growth factor-beta (TGF-β) receptor I inhibitors for cancer immunotherapy. TGF-β receptor I inhibitors (LY2157299, LY) were encapsulated to the PS via hydrophobic interaction, while CpG oligodeoxynucleotides were loaded onto the PS through electrostatic interaction. Compared to the control group, tumor inhibition in the PS-LY/CpG group was up to 99.7% without noticeable toxicity. The tumor regression may be attributed to T-cell activation and amplification in mouse models. The results highlight the additive effect of CpG and TGF-β receptor I inhibitors co-delivered in cancer immunotherapy. Keywords: CpG, TGF-β receptor I inhibitor, Pst-AAm copolymer nanosphere, immunotherapyLiang SYHu JXie YYZhou QZhu YHYang XLDove Medical PressarticleCpGTGF-β receptor I inhibitorPst-AAm co-polymer nanosphereimmunotherapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 6753-6762 (2016)
institution DOAJ
collection DOAJ
language EN
topic CpG
TGF-β receptor I inhibitor
Pst-AAm co-polymer nanosphere
immunotherapy
Medicine (General)
R5-920
spellingShingle CpG
TGF-β receptor I inhibitor
Pst-AAm co-polymer nanosphere
immunotherapy
Medicine (General)
R5-920
Liang SY
Hu J
Xie YY
Zhou Q
Zhu YH
Yang XL
A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice
description Shuyan Liang,* Jun Hu,* Yuanyuan Xie, Qing Zhou, Yanhong Zhu, Xiangliang Yang National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, People’s Republic of China *These authors contributed equally to this work Abstract: Cancer immunotherapy based on nanodelivery systems has shown potential for treatment of various malignancies, owing to the benefits of tumor targeting of nanoparticles. However, induction of a potent T-cell immune response against tumors still remains a challenge. In this study, polyethylenimine-modified carboxyl-styrene/acrylamide (PS) copolymer nanospheres were developed as a delivery system of unmethylated cytosine-phosphate-guanine (CpG) oligodeoxynucleotides and transforming growth factor-beta (TGF-β) receptor I inhibitors for cancer immunotherapy. TGF-β receptor I inhibitors (LY2157299, LY) were encapsulated to the PS via hydrophobic interaction, while CpG oligodeoxynucleotides were loaded onto the PS through electrostatic interaction. Compared to the control group, tumor inhibition in the PS-LY/CpG group was up to 99.7% without noticeable toxicity. The tumor regression may be attributed to T-cell activation and amplification in mouse models. The results highlight the additive effect of CpG and TGF-β receptor I inhibitors co-delivered in cancer immunotherapy. Keywords: CpG, TGF-β receptor I inhibitor, Pst-AAm copolymer nanosphere, immunotherapy
format article
author Liang SY
Hu J
Xie YY
Zhou Q
Zhu YH
Yang XL
author_facet Liang SY
Hu J
Xie YY
Zhou Q
Zhu YH
Yang XL
author_sort Liang SY
title A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice
title_short A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice
title_full A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice
title_fullStr A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice
title_full_unstemmed A polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of CpG and TGF-β receptor I inhibitor with remarkable additive tumor regression effect against liver cancer in mice
title_sort polyethylenimine-modified carboxyl-poly(styrene/acrylamide) copolymer nanosphere for co-delivering of cpg and tgf-β receptor i inhibitor with remarkable additive tumor regression effect against liver cancer in mice
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/14d3340247bf4804b5891b78c0fa4f48
work_keys_str_mv AT liangsy apolyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT huj apolyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT xieyy apolyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT zhouq apolyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT zhuyh apolyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT yangxl apolyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT liangsy polyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT huj polyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT xieyy polyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT zhouq polyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT zhuyh polyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
AT yangxl polyethyleniminemodifiedcarboxylpolystyreneacrylamidecopolymernanosphereforcodeliveringofcpgandtgfbetareceptoriinhibitorwithremarkableadditivetumorregressioneffectagainstlivercancerinmice
_version_ 1718403000253284352